1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Common Mechanisms in Autoimmunity Grants is sponsored by Breakthrough T1D (formerly JDRF), Lupus Research Alliance, and National Multiple Sclerosis Society. This grant program invites innovative ideas that address needs across multiple autoimmune diseases in novel ways. The objective is to develop new insights into the common mechanisms driving autoimmune diseases and accelerate the advancement of novel therapeutic strategies.
It seeks proposals from investigators across autoimmune and other relevant fields to advance the understanding of autoimmunity and obtain more specific insights into commonalities and differences of immune pathways governing these disease processes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Investigators across autoimmune and other relevant fields. Confirm the full requirements in the official notice before applying.
Common Mechanisms in Autoimmunity Grants is funded by Breakthrough T1D (formerly JDRF), Lupus Research Alliance, and National Multiple Sclerosis Society. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
CDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleNIH's FY2026 omnibus adds a Phase IIB Strategic Breakthrough Award up to $30M — but it requires a 100% outside match. Here's who it's for and how to plan.
Read articleNSF's rebuilt SBIR/STTR program (NSF 26-510) pairs a $305,000 Phase I with a brand-new Strategic Breakthrough award worth up to $30 million for the strongest Phase II companies. The next Project Pitch deadline is July 27, 2026. Here is how the non-dilutive funding ladder now works, why the Project Pitch gate decides everything, and how a founder should sequence the next twelve months.
Read article